Brief: Vaxil Initiates Pre-Clinical Study In New Oncology Target
13/10/2020 12:38
Oct 13 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL INITIATES PRE-CLINICAL STUDY IN NEW ONCOLOGY TARGET
* VAXIL BIO LTD - INITIATION OF PRE-CLINICAL PROGRAM FOR
IMMUCIN
IN COMBINATION WITH E-SELECTIN BINDING POLYMER-BASED THERAPEUTIC
Source text for Eikon: ID:nGNX1d0n3r
Further company coverage: VXL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover